Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Edwards Lifesciences (EW)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
OPERATING METRICS
REVENUE SOURCES
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for EW as compared to
Top Competitors
Medical Appliances & Equipment
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS (
See all
)
Revenue - Japan
►
171M
Revenue
Net Income
Operating Income
INCOME STATEMENT (
See all
)
Revenue
►
1.28B
HIGH
EBITDA
►
324M
HIGH
Net Income
►
220M
HIGH
Revenue Growth
►
5.2%
AVG
Net Income Growth
►
106%
AVG
Operating Margin
►
22%
HIGH
Net Margin
►
17.1%
HIGH
Revenue, Net Income, and Net Margin
Revenue, Gross Profit, and Gross Margin
Operating Income
Ebit
Income Before Taxes
Net Income from Continuing Ops
Interest vs Continuing Income
Interest Coverage
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
0.469
AVG
Current Ratio
►
2.96
AVG
Quick Ratio
►
2.39
AVG
Interest Coverage Ratio
►
87.2
HIGH
Book Value Per Share
►
19.3
Cash Per Share
►
5.09
Loading...
STOCK SUMMARY
Open
0.00
Day Range
82.08
-
82.88
52 Week Range
52.86
-
83.09
Volume
0
Avg Volume (3 mo)
377K
Shares Outstanding
56.4M
Market Cap
4.65B
VALUATION
Price to Earnings (P/E)
►
20.7
AVG
Price to Book (P/B)
►
4.18
HIGH
Price to Sales (P/S)
►
3.55
HIGH
Return on Assets (ROA)
►
14.9%
HIGH
Return on Equity (ROE)
►
22.4%
AVG
EV/EBITDA
►
15.3
AVG
Dividend Yield
0%
AVG
ANALYST RECOMMENDATIONS
OWNERSHIP
Net Insider Buying 3mo
-21.8%
Net Insider Buying 6mo
-31.7%
Net Insider Buying 1yr
-48.9%
Held by insiders
1.2%
Held by institutions
66.9%